Need all Congresses? Press Enter for expanded federal results.

SB 274

Delaware Senate bill in Session 153.

Status: passed_lower. Latest action: May 13, 2026.

AN ACT TO AMEND TITLE 16 AND TITLE 21 OF THE DELAWARE CODE RELATING TO DELAWARE MEDICAL ORDERS FOR SCOPE OF TREATMENT.

Bill ID DE-153-SB-274
Session 153
Status passed_lower
Committee Health & Social Services
Senate passed_lower 2026-05-13
Summary

Enacted in 2015, Chapter 25A of Title 16, the Delaware Medical Orders for Scope of Treatment Act created a voluntary process and a document that can used by patients with serious illness or frailty to provide direction to emergency care personnel regarding the patient's preferences in regard to scope of care and treatment. This Act changes the name "Delaware Medical Orders for Scope of Treatment (DMOST)"" under Chapter 25A of Title 16 to ""Delaware Portable Orders for Life-Sustaining Treatment (POLST)"" to align with the national effort to create a uniform form. This Act contains a savings provision so that the name change under this Act does not affect the validity or effect of DMOST forms. This Act also revises Chapter 25A of Title 16 as follows: • Repeals requirements that conflict with the national model law regarding a patient’s ability to limit the future authority of the patient’s authorized representative to modify the orders in the patient’s POLST form. • Allows any health-care practitioner authorized under Chapter 25A of Title 16 to complete a POLST form to find that a patient lacks sufficient decision-making capacity to execute a POLST form. Under existing law, all practitioners who are licensed and authorized to write medical orders under Title 24 may complete POLST forms but only physicians can determine that a patient lacks sufficient decision-making capacity to execute a POLST form. This change is consistent with the capacity provisions under Chapter 25 of Title 16, the recently enacted Uniform Health-Care Decisions Act. • Requires that a health-care practitioner document their finding that a patient lacks decision-making capacity in the patient’s medical record. • Clarifies the existing requirement that a patient’s authorized representative may not execute a POLST form for a patient unless the patient’s lack of decision-making capacity is documented in the patient’s medical record. Makes technical corrections to conform existing law to the standards of the Delaware Legislative Drafting Manual, including corresponding name changes to other Code sections that reference the DMOST form. In § 2718(c)(5) of Title 21, the name for an advance health-care directive under Chapter 25 of Title 16 is also corrected."

Sponsor
Pinkney
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-04-09 Introduced Bill introduced
2026-05-13 Status passed_lower
2026-05-13 Latest Action Assigned to Health & Human Development Committee in House
More Bills From This Sponsor
SA 1 to SB 320
by inserting the following before line 1 and redesignating the sections of this Act accordingly: “Section 1. Amend § 3002G, Title 16 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows: § 3002G. Definitions [For application of this section, see 85 Del. Laws, c. 253, § 23]. For purposes of this chapter: (1) “Health-care practitioner” means an individual licensed under Title 24 as any of the following: a. A physician. b. An advanced practice registered nurse. c. A physician associate. d. A pharmacist. ”. FURTHER AMEND Senate Bill No. 320 by inserting between lines 174 and 175 the following: “ § 2569. Malpractice reporting requirements. (a) A pharmacist practicing under this chapter shall inform the Board in writing of any medical malpractice claim against the pharmacist that has been settled or adjudicated to final judgment (“judgment”). A medical or pharmaceutical insurance carrier who has provided coverage on the malpractice claim shall also inform the Board in writing of the malpractice claim. Notice required to be made under this subsection must be filed with the Board within 30 days of the settlement or judgment. (b) The Board shall refer a notice of medical malpractice made in accordance with subsection (a) of this section to the Division of Professional Regulation to be investigated. The Board must make the referral to the Division of Professional Regulation within 60 days of receiving notice under subsection (a) of this section. ”. FURTHER AMEND Senate Bill No. 320 on line 175 by deleting “ § 2569. ” and inserting in lieu thereof the following: “ § 2570. ”.
introduced • Senate
SS 1 for SB 161
AN ACT TO AMEND TITLES 16 AND 29 OF THE DELAWARE CODE RELATING TO BEHAVIORAL HEALTH.
passed_lower • Senate
SB 334
AN ACT TO AMEND TITLES 18 AND 29 OF THE DELAWARE CODE RELATING TO HEALTH CARE.
introduced • Senate
SB 330
AN ACT TO AMEND TITLE 29 OF THE DELAWARE CODE RELATING TO THE DELAWARE AFRICAN AMERICAN HERITAGE AND CULTURE COMMISSION.
introduced • Senate
SB 226
AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO MEDICAL MARIJUANA.
enacted • Senate
SB 301
AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO HOSPITAL DISCHARGE PLANS FOR PREGNANT PATIENTS.
passed_lower • Senate
More Bills In This Topic
Related Topics
Same Topic Bills From Other States